POINT Biopharma Global (PNT) Q3 2023 Earnings

13NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-0.31
-0.26
-0.21
-0.16

Details

Expected EPS
-0.3
Actual EPS
-0.23
Surprise EPS
0.07
Surprise Percent
+23.33%

Description

POINT Biopharma Global (PNT) has reported earnings of -0.23 per share for Q3 2023.

0 Comments

Share your thoughts